Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients

Not Applicable

Completed

• Conditions: Venous Thromboembolism
• Interventions: Other: Electronic alert and the Geneva Risk Score calculation tool issued in the electronic patient chart

• Registration Number: NCT03124017
• Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Brief Summary

The investigators aim to investigate whether a computer-based alert system in the electronic patient chart and order entry system using the Geneva Risk Score as clinical decision support tool to estimate the risk of venous thromboembolism improves the rate of appropriate thromboprophylaxis among hospitalized medical patients.

Detailed Description

The use of thromboprophylaxis among acutely ill hospitalized medical patients remains inconsistent. The present study aims to improve the use of appropriate thromboprophylaxis by implementing a computer-based alert system combined with a Geneva Risk Score calculation tool in the electronic patient chart and order entry system. Consecutive acutely ill medical patients without indication for therapeutic anticoagulation or ongoing therapeutic anticoagulant treatment admitted to the medical wards of the University Hospital Bern, Switzerland, will be randomized in a 1:1 fashion to the alert group in which an alert and the Geneva Risk Score calculation tool will be issued in the electronic patient chart or to the control group in which no alert will be issued. The primary endpoint is the rate of appropriate thromboprophylaxis during hospital stay.

Study Timeline

• Study Start: 2015-03
• Primary Completion: 2016-03
• Study Completion: 2016-06
• Status Verified: 2017-04
• Study First Submitted: 2017-04-18
• Study First Submitted QC: 2017-04-18
• Last Update Submitted: 2017-04-18
• Study First Posted: 2017-04-21
• Last Update Posted: 2017-04-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1756

Inclusion Criteria

• Acutely ill medical patients admitted to medical wards

Exclusion Criteria

• Indication for therapeutic anticoagulation or ongoing therapeutic anticoagulant treatment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Alert Group	Electronic alert and the Geneva Risk Score calculation tool issued in the electronic patient chart	Electronic alert and the Geneva Risk Score calculation tool issued in the electronic patient chart

Primary Outcome Measures

Name	Time	Method
Rate of appropriate thromboprophylaxis	During hospital stay (expected average duration of 1 week)

Secondary Outcome Measures

Name	Time	Method
Rate of correct calculation of the Geneva Risk Score through the calculation tool by the physician in charge	During hospital stay (expected average duration of 1 week)
Use of the Geneva Risk Score calculation tool by the physician in charge	During hospital stay (expected average duration of 1 week)

Trial Locations

Locations (1)

Swiss Cardiovascular Center, Inselspital, University of Bern; 🇨🇭 Bern, Switzerland